Parima Notches Third Approval Milestone in a Year With FSANZ Safety Assessment Completion

Cultivated protein company Parima has achieved a significant milestone by completing the core safety risk assessment stage of FSANZ's novel food approval process for its cultivated duck, becoming the first company outside Australia and New Zealand to reach this point in the pathway. This marks the third approval milestone for Parima in a year, following previous approvals from the Singapore Food Agency for cultivated chicken and duck. The assessment confirmed that Parima's production cell line is non-genetically modified and meets safety standards through genomic and karyotyping analyses.

With the core safety review completed, Parima's application now moves to public consultation before a final approval decision is made. The company expressed gratitude for FSANZ's efficiency in the review process and highlighted the validation of its production platform across two species and two jurisdictions. Parima is actively pursuing regulatory approvals in Europe, Asia, and North America, building a strong portfolio of regulatory clearances for its cultivated meat products.